The mechanism seeks to address monopolistic dynamics that can limit market access, constrain pricing flexibility and increase vulnerability to supply interruptions The Emirates Drug Establishment (EDE) has announced the activation of a new regulatory mechanism requiring pharmaceutical companies to appoint more than one agent for each medical product registered in the UAE, in a move aimed at ending monopolistic practices and strengthening national drug security. The measure, described as the first...

With the obesity market projected to exceed $130 billion by 2034, many major pharmaceutical players are rapidly advancing pipelines to capitalize on what is arguably the most dynamic space in the industry. To identify the companies positioned to outperform, FENIX has created the Obesity Power Rankings of the Top 10 players. For context, >20 companies were assessed across more than 15 weighted criteria, including pipeline depth, clinical differentiation, and commercial infrastructure, to derive a composite score out of five. If you’re interested in a deeper look at the full...